Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Rhomboid Intercostal Block vs Erector Spinae Block

Assessing the Effectiveness of Rhomboid Intercostal and Erector Spinae Plane Blocks After Lung Cancer Thoracotomy

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This randomized trial compares rhomboid intercostal block (RIB) and erector spinae plane block (ESPB) for postoperative pain control in lung cancer patients undergoing thoracotomy. Sixty patients will be assessed for 24-hour morphine consumption, pain scores, hemodynamics, recovery time, satisfaction, and side effects. The study aims to identify the more effective technique for enhancing recovery and minimizing opioid use.

Who May Be Eligible (Plain English)

Who May Qualify: - patients undergoing thoracotomy for lung cancer Age ≥ 18 years and ≤ 65 years ASA physical status II or III Body Mass Index (BMI) \> 20 kg/m² and \< 35 kg/m² Willing and able to provide willing to sign a consent form Who Should NOT Join This Trial: Patient refusal ASA physical status IV Age \< 18 years or \> 65 years BMI \< 20 kg/m² or \> 35 kg/m² Known allergy or contraindication to local anesthetics or opioids used in the study History of chronic pain or psychological disorders Contraindications to regional anesthesia (e.g., local infection, coagulopathy, pre-existing peripheral neuropathy) Severe respiratory, cardiac, hepatic, or renal disease \- Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * patients undergoing thoracotomy for lung cancer Age ≥ 18 years and ≤ 65 years ASA physical status II or III Body Mass Index (BMI) \> 20 kg/m² and \< 35 kg/m² Willing and able to provide informed consent Exclusion Criteria: Patient refusal ASA physical status IV Age \< 18 years or \> 65 years BMI \< 20 kg/m² or \> 35 kg/m² Known allergy or contraindication to local anesthetics or opioids used in the study History of chronic pain or psychological disorders Contraindications to regional anesthesia (e.g., local infection, coagulopathy, pre-existing peripheral neuropathy) Severe respiratory, cardiac, hepatic, or renal disease \-

Treatments Being Tested

PROCEDURE

Ultrasound-guided Rhomboid Intercostal Block

This intervention involves an ultrasound-guided injection of 20-25 mL of 0.25% bupivacaine into the fascial plane between the rhomboid major and intercostal muscles. The patient is positioned laterally, and the block is performed at the T5-T6 level using a high-frequency linear ultrasound probe. The goal is to anesthetize the lateral cutaneous branches of the intercostal nerves to provide postoperative thoracic analgesia.

PROCEDURE

Ultrasound-guided Erector Spinae Plane Block

This intervention consists of an ultrasound-guided injection of 20-25 mL of 0.25% bupivacaine into the plane deep to the erector spinae muscle at the T4-T5 transverse process level. The patient is positioned sitting or in lateral decubitus, and the procedure uses a curved or linear ultrasound probe. This block targets the dorsal and ventral rami of thoracic spinal nerves to manage postoperative pain after thoracotomy.

Locations (1)

National Cancer Institute - Cairo University
Cairo, Egypt